Trial intelligence / Profile preview

Vitamin D or placebo in treatment of uterine leiomyoma

IRCT2014121511019N4Phase 3Completed

Sponsor
Semnan University of Medical Sciences
Start
Jan 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Fibromyoma (LM) comparing Vitamin D with Placebo (2 arms). Primary endpoints: Leiomyoma size change, Menstrual volume and 1 more. Started Jan 2015; status: completed.

02

Drugs

vitamin d
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on IRCT2014121511019N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014121511019N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call